Physician profile
Albert B Knapp
NPI 1043311574
$4,361.56
in general payments reported to CMS, 2019-2025
8 companies · $4,243 in 2025
The $4,243 reported for 2025 was more than what 90% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.16 · 2022: $11.71 · 2024: $56.69 · 2025: $4,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $4,177 · Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $4,177.02 |
| Food and Beverage | $122.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $4,177.02 | 2025 | Disposable Biopsy Forceps |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.49 | 2024-2025 | Xifaxan |
| Ironwood Pharmaceuticals, INC | $43.80 | 2019 | |
| Janssen Biotech, INC. | $27.62 | 2024 | Stelara |
| Abbvie INC. | $21.28 | 2025 | |
| Braintree Laboratories, INC. | $13.28 | 2024 | Sutab |
| Lilly USA, LLC | $11.71 | 2022 | |
| Romark Laboratories, Lc | $6.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Knapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.